In active inflammatory bowel disease, a significant two‐fold higher expression of AIM2 and IFI16 is observed in the intestinal mucosa compared with controls,104, 105 indicating priming/upregulation of these proteins in certain conditions involving barrier function integrity. This evidence concerns the gene AIM2 and inflammatory bowel disease.